Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jixin Zhong

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|October 7, 2015
Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular DiseaseJixin Zhong, Sanjay Rajagopalan
Annals of the Rheumatic Diseases|July 26, 2020
Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan <i>et al</i>Jixin Zhong, Lingli Dong
Frontiers in Immunology|April 30, 2019
Editorial: Regulation of Inflammation in Chronic DiseaseJixin Zhong, Guixiu Shi
Current Opinion in Lipidology|July 30, 2016
Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studiesJixin Zhong, Saumya Kankanala, Sanjay Rajagopalan
International Journal of Cardiology|July 5, 2015
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent functionQuan Gong, Sanjay Rajagopalan, Jixin Zhong
Life Sciences|September 30, 2014
The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetesXiaoquan Rao, Jixin Zhong, Qinghua Sun
Frontiers in Endocrinology|October 19, 2020
Editorial: Cross Talk Between the Immune System and MetabolismJie Chen, Wen Kong, Jixin Zhong
Clinical Lipidology|May 26, 2015
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsJixin Zhong, Andrei Maiseyeu, Sanjay Rajagopalan
Frontiers in Medicine|September 30, 2021
IL-33 in Rheumatic DiseasesYuanji Dong, Jixin Zhong, Lingli Dong
Atherosclerosis|October 23, 2012
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular diseaseJixin Zhong, Xiaoquan Rao, Sanjay Rajagopalan
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|October 7, 2015
Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular DiseaseJixin Zhong, Sanjay Rajagopalan
Annals of the Rheumatic Diseases|July 26, 2020
Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan <i>et al</i>Jixin Zhong, Lingli Dong
Frontiers in Immunology|April 30, 2019
Editorial: Regulation of Inflammation in Chronic DiseaseJixin Zhong, Guixiu Shi
Current Opinion in Lipidology|July 30, 2016
Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studiesJixin Zhong, Saumya Kankanala, Sanjay Rajagopalan
International Journal of Cardiology|July 5, 2015
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent functionQuan Gong, Sanjay Rajagopalan, Jixin Zhong
Life Sciences|September 30, 2014
The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetesXiaoquan Rao, Jixin Zhong, Qinghua Sun
Frontiers in Endocrinology|October 19, 2020
Editorial: Cross Talk Between the Immune System and MetabolismJie Chen, Wen Kong, Jixin Zhong
Clinical Lipidology|May 26, 2015
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitorsJixin Zhong, Andrei Maiseyeu, Sanjay Rajagopalan
Frontiers in Medicine|September 30, 2021
IL-33 in Rheumatic DiseasesYuanji Dong, Jixin Zhong, Lingli Dong
Atherosclerosis|October 23, 2012
An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular diseaseJixin Zhong, Xiaoquan Rao, Sanjay Rajagopalan
Pageof 15